OilSafe’s Post

On May 10, Diego Disperati and Giuseppe Aprea, two of the members representing CSV life Science Group, signed a 𝗠𝗲𝗺𝗼𝗿𝗮𝗻𝗱𝘂𝗺 𝗼𝗳 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 in Rome with the Iraqi company Kar Insurance كار للتأمين for the development of new and important projects to support the pharmaceutical sector in the country. SACE, the Ministero dell'Economia e delle Finanze's insurance-financial group, concretized and operationalized this meeting through a Framework Agreement with the المصرف العراقي للتجارة_Trade Bank of Iraq . The new investments will allow to increase Made in Italy exports to Iraq and, in the case of CSV Life Science Group, to further contribute to the development of the pharmaceutical sector operated by private investors. Our Group has a long and deep knowledge of the Iraqi market, as it has been present in the area for years with projects involving several of our branches.  We will keep you updated on the developments of this new and exciting challenge. Ministero dell'Economia e delle Finanze #iraq #agreement #madeinitaly #lifescience #csvlifesciencegroup #investment #collaboration #development

The latest #mpox #outbreak has highlighted gaps in #vaccineproduction in #Africa. Several major #pharma companies have tried to set up #manufacturing facilities in Africa, but have found it difficult due to a variety of reasons. How will #bigpharma continue their operations in the region? Read my take here: https://lnkd.in/gCVAb8hA

The draft standard for #cyclospora is now available for public comment! Review and submit via the link below. #aoac #cyclospora #standardsdevelopment

#France's #Sanofi could become the latest #bigpharma company to exit the #consumerhealthcare #business. It is in talks to sell a 50% #controllingstake in its #consumer #health unit #Opella, which employs over 11,000 people and has operations in 100 countries. Sanofi’s move follows similar divestments by other #pharmaceutical #companies such as #GSK and #JNJ. Consumer healthcare will remain a key segment, given strong #demand for #everydayproducts like #vitamins, #skincare and #cosmetics. Then why are these #pharma companies exiting consumer health? Will others follow suit? Read my take here: https://lnkd.in/gRsTRatW

UK healthcare professionals - do you want to learn more about clinical trial design for advanced therapy investigational medicinal products (ATIMPs)? The ATTC Network have developed an e-learning module, as part of their extensive training series focused on #AdvancedTherapies, which provides a refresher of standard clinical trial studies and explains the additional features which impact trial design for ATIMPs and how they can be addressed. Sign in via your e-Learning for Healthcare account to access: https://buff.ly/3r9BH9e #CellTherapy #GeneTherapy #ATTC #ClinicalTrials #ATMPs #AdvancedTherapies

Ahmed Kelani's presentation @ 2nd International Congress &Exhibition PHARMA QAZAQSTAN & CENTREAL ASIA, 9-10 April 2024, Almaty- Kazakhstan As an honorary guest of the conference on #ACDIMA, EIPICO vision towards #Global_Manufacturing_Expansion through establishing pharmaceutical factories in some of important territories, such as: #east_west_Africa & #Central_Asia to maintain our products sustainability in these markets, and using these factories as #Hubs to facilitate our products penetration into the nearby countries. This is a practical & dramatic change in the traditional Concept of the Drug Export. #ACDIMA #EIPICO #Global_Manufacturing_Expansion #EIPICO3 #Biosimilar #Biological #Arab_API

What after KAPS? Post Result Session With Mr. Arief Mohammad | KAPS November '23 #kaps #austalia Join Mr. Arief Mohammad in our comprehensive session as we explore the AHPRA registration pathway for pharmacists. In this pivotal discussion, we will delve into the critical steps you need to take after passing the KAPS exam, guiding you through the intricate process of securing your registration with the Australian Health Practitioner Regulation Agency (AHPRA). This session is tailor-made for international pharmacy graduates who have successfully navigated the Knowledge Assessment of Pharmaceutical Sciences (KAPS) exam and are looking to advance to the next stage of their professional journey in Australia. Mr. Mohammad will offer valuable insights into preparing your application, meeting AHPRA's stringent requirements, and what to expect during the assessment process. Whether you're uncertain about the documentation needed, the timeline for application, or how to present your qualifications and experience, this session promises to shed light on these areas and more. It's an unmissable opportunity for those aiming to practice pharmacy in Australia and seeking clarity on the AHPRA registration pathway. Don't let the complexities of the registration process deter your aspirations. Equip yourself with the knowledge and confidence to move forward in your pharmacy career by joining us this session. Watch it on: https://lnkd.in/gzdURcUd

IBSA is preparing to celebrate 40 years of success, innovation and growth. Founded in 1945 – but acquired by Arturo Licenziati [only] in 1985 – the company has grown from a small reality to a multinational with over 2,300 collaborators. The stories of those who were there from the beginning testify to strong human bonds and values that have never changed. Let’s prepare to celebrate this milestone together, looking with pride at the past and with confidence at the future.   🔹 Discover the stories of IBSA’s first collaborators in our latest news: https://lnkd.in/dzfBh9rf #IBSA #CaringInnovation #WeAreIBSA Maria Teresa Gilardoni, Rosalba Brogna, Monia Pieroni, Stefano Rovati, Michela Ricci - Lazzaroni, IBSA Austria, IBSA France, IBSA Germany, IBSA Italy, IBSA Iberia, IBSA Nordic, IBSA Poland, IBSA Slovakia, IBSA Switzerland | SBO, IBSA UK, IBSA USA

Check out the important article about DADI from true world-class experts! #TOPRA

🤔 The interesting thing about attending World Orphan Drug Congress USA this year was that I no longer had to educate people on the idea of the Middle East. 📚 For years, I have been working on educating teams working in the US & Europe on why a Middle-East inclusive strategy is important and what is being missed by having a unidimensional view on commercial launch sequencing. 💡 This time was different. 🗣 For the first time ever, companies were proactively thinking about our region early on. Some key speakers, even. (*shhh, no names!*). 🎉 It's an extremely exciting time for our region. ✅ For those of you that are still thinking about it, now is your chance. 🇸🇦 Here's a snapshot of the Saudi market to get you started. #MarketAccess #CommercialGoals #SaudiArabia #MENAFirst #RareDisease #OrphanDrug #CountrySnapshot #MarketReport